Ophthalmology And Visual Sciences

A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered. Read More

A memorial service for Professor Vivien Casagrande is planned for April 12 in Benton Chapel. Read More

Milam Brantley Jr., M.D., Ph.D., associate professor of Ophthalmology and Visual Sciences and Molecular Physiology and Biophysics, recently received a $500,000 grant from the Edward N. and Della L. Thome Memorial Foundation Awards Program in Macular Degeneration Research to further his work on age-related macular degeneration (AMD). Read More

Colleagues of Vivien Casagrande, Ph.D., celebrated her distinguished career in the visual sciences with a “Lifetime of Vision” symposium Nov. 18 in Biological Sciences/Medical Research Building III. Read More

With the end of daylight saving time, ophthalmologists at the Vanderbilt Eye Institute want to focus on a real issue—dim-light driving situations that can endanger drivers and pedestrians. Read More

Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology. Read More

When it comes to sun safety, most people are quick to grab a hat and lather on sunscreen. Doctors at the Vanderbilt Eye Institute want consumers to be on the lookout for another protective measure – sunglasses. Read More

For the past few months, most of the nation has donned hats, boots, scarves and gloves as they have faced brutally cold and icy conditions of winter. As temperatures rise, making outdoor activities more enticing, Vanderbilt ophthalmologists suggest not to be in such… Read More

Since 1961, the Eye Bank Association of America has provided donors for more than 1.5 million corneal transplants nationwide. And for nearly 25 years, the group has celebrated corneal transplant recipients, promoted awareness of the need to donate and recognized donors and families during National Eye Donor Month in March. Read More

Tonia Rex, Ph.D., and colleagues at the Vanderbilt Eye Institute are working to uncover how best to treat ocular trauma, the fourth leading cause of blindness worldwide. Read More

Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults. Read More

David Morrison, M.D., associate professor of Ophthalmology and Pediatrics at Vanderbilt, is the new president of the American Orthoptic Council (AOC). He will serve a two-year term. Read More

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children. Read More

The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000. Read More

A Celebration of Life service for James Howard Elliott, M.D., will be held Sunday, May 17, at noon at Benton Chapel. Read More

For the past few months, much of the nation has donned hats, boots, scarves and gloves as they face brutally cold and icy conditions of winter. As temperatures rise, making outdoor activities more enticing, Vanderbilt ophthalmologists suggest not to be in such a hurry to stop protecting… Read More

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions. Read More

Twelve members of Vanderbilt's faculty have been elected fellows of the American Association for the Advancement of Science for their “scientifically or socially distinguished efforts to advance science or its applications.” Read More

It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched. Read More

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo. Read More